In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of m. genitalium-positive nongonococcal urethritis in men

Clinical Infectious Diseases

Volumn 41, Issue 9, 2005, Pages 1357-1359

  Yasuda, M ^a   Maeda, S ^a   Deguchi, Takashi ^a,b  

^a GIFU UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; TOSUFLOXACIN;

ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; NONSPECIFIC URETHRITIS; PRIORITY JOURNAL;

FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; URETHRITIS;

EID: 27444446953     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/496983     Document Type: Article

References (13)

1. Maeda SI, Tamaki M, Kojima K, et al. Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis. Sex Transm Dis 2001; 28:472-6.
2. Pereyre S, Renaudin H, Bebear C, Bebear CM. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas. Antimicrob Agents Chemother 2004; 48:3165-8.
3. Bebear CM, Renaudin H, Bryskier A, Bebear C. Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas. Antimicrob Agents Chemother 2000; 44:1980-2.
4. Bebear CM, Renaudin H, Charron A, Gruson D, Lefrancois M, Bebear C. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 2000; 44:2557-60.
5. Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother 2000; 45(Suppl 1):29-33.
6. Renaudin H, Tully JG, Bebear C. In vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrob Agents Chemother 1992; 36:870-2.
7. Bebear CM, Renaudin H, Schaeverbeke T, Leblanc F, Bebear C. In vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. J Antimicrob Chemother 1999; 43:711-4.
8. Hannan PC, Woodnutt G. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. J Antimicrob Chemother 2000; 45:367-9.
9. Waites KB, Crabb DM, Duffy LB. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother 2003; 47:3973-5.
10. Johannisson G, Enstrom Y, Lowhagen GB, et al. Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden. Int J STD AIDS 2000; 11:324-6.
11. Horner PJ, Gilroy CB, Thomas BJ, Naidoo RO, Taylor-Robinson D. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet 1993; 342:582-5.
12. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect 2003; 79:318-9.
13. Gambini D, Decleva I, Lupica L, Ghislanzoni M, Cusini M, Alessi E. Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication. Sex Transm Dis 2000; 27:226-9.